Beyond functional disability: longitudinal joint trajectories of muscle strength and walking speed and their association with new-onset diabetes risk among older adults without ADL impairment.
Source check: Source checked. Not independent scientific confirmation.
Finding: Longitudinal trajectories of muscle strength and walking speed across four aging cohorts were associated with new-onset diabetes among older adults without ADL impairment; this is observational.
Technology: Machine-learning clustering of longitudinal muscle-strength and walking-speed trajectories
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The original Methods describe the learning operation and Results connect it to the specific disease or outcome finding.
- Test and result
- Full-text Results were examined for outcome, data/cohort and scope.
- Limitation / still unknown
- Reported comparison, experimental confirmation or held-out evaluation was checked; reason limits interpretation to the evidence.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3389/fendo.2026.1935223 · https://europepmc.org/article/MED/43016806 · https://www.frontiersin.org/journals/genetics/articles/fendo.2026.1935223/full · https://pubmed.ncbi.nlm.nih.gov/43016806/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.